Skip to main content
main-content
Erschienen in: HNO Nachrichten 2/2022

19.04.2022 | Oropharynxkarzinom | Zertifizierte Fortbildung

Steigende Inzidenz

HPV-assoziierte Oropharynxkarzinome: Einschätzung des Erkrankungsrisikos

verfasst von: Dr. med. Christian Jacobi, Dr. med. Ivelina Stoycheva

Erschienen in: HNO Nachrichten | Ausgabe 2/2022

zum CME-Kurs Einloggen, um Zugang zu erhalten

Auszug

Die Zahl der HPV-assoziierten Oropharynxkarzinome steigt weltweit. Und auch die Berichterstattung in den Medien mit einem Bezug auf die sexuelle Übertragbarkeit von HPV nimmt zu. Das führt oft zu Verunsicherung bei Patienten. Daher ist es wichtig, die potenziellen Risikofaktoren und die Zahlen zum Erkrankungsrisiko zu kennen. So können Sie alle Fragen kompetent einordnen und beantworten.
Literatur
1.
Zurück zum Zitat Zentrum für Krebsregisterdaten. Krebs in Deutschland für 2017/2018, 13. Ausgabe. Berlin: Robert Koch-Institut; 2021 Zentrum für Krebsregisterdaten. Krebs in Deutschland für 2017/2018, 13. Ausgabe. Berlin: Robert Koch-Institut; 2021
2.
Zurück zum Zitat S3-Leitlinie "Impfprävention HPV-assoziierter Neoplasien. AWMF-Registernr. 082-002; Stand Mai 2020 S3-Leitlinie "Impfprävention HPV-assoziierter Neoplasien. AWMF-Registernr. 082-002; Stand Mai 2020
3.
Zurück zum Zitat Jansen L et al. Mundhöhlen- und Pharynxkarzinome: Inzidenz, Mortalität und Überleben in Deutschland. Bundesgesundheitsbl. 2021; 64:941-50 Jansen L et al. Mundhöhlen- und Pharynxkarzinome: Inzidenz, Mortalität und Überleben in Deutschland. Bundesgesundheitsbl. 2021; 64:941-50
4.
Zurück zum Zitat Plummer M et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4:e609-16 Plummer M et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4:e609-16
5.
Zurück zum Zitat Gillison ML et al. Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma. J Clin Oncol. 2015;33:3235-42 Gillison ML et al. Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma. J Clin Oncol. 2015;33:3235-42
6.
Zurück zum Zitat Tota JE et al. Epidemiology and burden of HPV infection and related diseases: Implications for prevention strategies. Prev Med. 2011; 53(Suppl 1):S12-21 Tota JE et al. Epidemiology and burden of HPV infection and related diseases: Implications for prevention strategies. Prev Med. 2011; 53(Suppl 1):S12-21
7.
Zurück zum Zitat Senkomago V et al. Human Papillomavirus-Attributable Cancers — United States, 2012-2016. MMWR Morb Mortal Wkly Rep. 2019;68:724-8 Senkomago V et al. Human Papillomavirus-Attributable Cancers — United States, 2012-2016. MMWR Morb Mortal Wkly Rep. 2019;68:724-8
8.
Zurück zum Zitat Vlachea P. Etablierung eines RT-PCR-Assays zum Nachweis von E6/E7-Onkogen-Transkripten aus archiviertem Paraffingewebe von Plattenepithelkarzinomen der Kopf-Hals-Region [dissertation]. München: LMU; 2021 Vlachea P. Etablierung eines RT-PCR-Assays zum Nachweis von E6/E7-Onkogen-Transkripten aus archiviertem Paraffingewebe von Plattenepithelkarzinomen der Kopf-Hals-Region [dissertation]. München: LMU; 2021
9.
Zurück zum Zitat Buttmann-Schweiger N et al. Cancer incidence in Germany attributable to human papillomavirus in 2013. BMC Cancer. 2017;17:682 Buttmann-Schweiger N et al. Cancer incidence in Germany attributable to human papillomavirus in 2013. BMC Cancer. 2017;17:682
10.
Zurück zum Zitat Stanley M. Perspective: Vaccinate boys too. Nature. 2012;488:S10 Stanley M. Perspective: Vaccinate boys too. Nature. 2012;488:S10
11.
Zurück zum Zitat Stein AP et al. Prevalence of Human Papillomavirus in Oropharyngeal Squamous Cell Carcinoma in the United States Across Time. Chem Res Toxicol. 2014;27:462-9 Stein AP et al. Prevalence of Human Papillomavirus in Oropharyngeal Squamous Cell Carcinoma in the United States Across Time. Chem Res Toxicol. 2014;27:462-9
12.
Zurück zum Zitat Ndiaye C et al. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol. 2014;15:1319-31 Ndiaye C et al. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol. 2014;15:1319-31
13.
Zurück zum Zitat Mehanna H et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck, vol. 35, no. 5, pp. 747-755, May 2013, doi: 10.1002/hed.22015. Mehanna H et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck, vol. 35, no. 5, pp. 747-755, May 2013, doi: 10.1002/hed.22015.
14.
Zurück zum Zitat Rettig E et al. The role of sexual behavior in head and neck cancer: implications for prevention and therapy. Expert Rev Anticancer Ther. 2015;15:35-49 Rettig E et al. The role of sexual behavior in head and neck cancer: implications for prevention and therapy. Expert Rev Anticancer Ther. 2015;15:35-49
15.
Zurück zum Zitat Van Dyne EA et al. Trends in Human Papillomavirus-Associated Cancers — United States, 1999-2015. MMWR Morb Mortal Wkly Rep. 2018;67:918-24 Van Dyne EA et al. Trends in Human Papillomavirus-Associated Cancers — United States, 1999-2015. MMWR Morb Mortal Wkly Rep. 2018;67:918-24
16.
Zurück zum Zitat Tota JE et al. Evolution of the Oropharynx Cancer Epidemic in the United States: Moderation of Increasing Incidence in Younger Individuals and Shift in the Burden to Older Individuals. J Clin Oncol. 2019;37:1538-46 Tota JE et al. Evolution of the Oropharynx Cancer Epidemic in the United States: Moderation of Increasing Incidence in Younger Individuals and Shift in the Burden to Older Individuals. J Clin Oncol. 2019;37:1538-46
17.
Zurück zum Zitat Chaturvedi AK et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29:4294-301 Chaturvedi AK et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29:4294-301
18.
Zurück zum Zitat Braakhuis BJM et al. Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011. Oral Oncol. 2014;50:670-5 Braakhuis BJM et al. Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011. Oral Oncol. 2014;50:670-5
19.
Zurück zum Zitat Prigge ES et al. p16(INK4a) /Ki-67 co-expression specifically identifies transformed cells in the head and neck region. Int J Cancer. 2015;136:1589-99 Prigge ES et al. p16(INK4a) /Ki-67 co-expression specifically identifies transformed cells in the head and neck region. Int J Cancer. 2015;136:1589-99
20.
Zurück zum Zitat Wittekindt C et al. Oropharynxkarzinome: Wenn humane Papillomviren die Tumorauslöser sind. Dtsch Arztebl. 2018;115:[10] Wittekindt C et al. Oropharynxkarzinome: Wenn humane Papillomviren die Tumorauslöser sind. Dtsch Arztebl. 2018;115:[10]
21.
Zurück zum Zitat Smith EM et al. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer. 2004;108:766-72 Smith EM et al. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer. 2004;108:766-72
22.
Zurück zum Zitat Kreimer AR et al. Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis. 2010;37:386-91 Kreimer AR et al. Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis. 2010;37:386-91
23.
Zurück zum Zitat Beachler DC et al. Natural History of Anal vs Oral HPV Infection in HIV-Infected Men and Women. J Infect Dis. 2013;208:330-9 Beachler DC et al. Natural History of Anal vs Oral HPV Infection in HIV-Infected Men and Women. J Infect Dis. 2013;208:330-9
24.
Zurück zum Zitat Lang Kuhs KA et al. Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A Pooled Analysis. Cancer Epidemiol Biomarkers Prev. 2015;24:683-9 Lang Kuhs KA et al. Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A Pooled Analysis. Cancer Epidemiol Biomarkers Prev. 2015;24:683-9
25.
Zurück zum Zitat Steinau M et al. Prevalence of Cervical and Oral Human Papillomavirus Infections Among US Women. J Infect Dis. 2014;209:1739-43 Steinau M et al. Prevalence of Cervical and Oral Human Papillomavirus Infections Among US Women. J Infect Dis. 2014;209:1739-43
26.
Zurück zum Zitat Kreimer AR et al. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet. 2013;382:877-87 Kreimer AR et al. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet. 2013;382:877-87
27.
Zurück zum Zitat Wittekindt C et al. HPV - Das andere Kopf-Hals-Karzinom. Laryngo-Rhino-Otologie. 2018;97:S48-S81 Wittekindt C et al. HPV - Das andere Kopf-Hals-Karzinom. Laryngo-Rhino-Otologie. 2018;97:S48-S81
28.
Zurück zum Zitat Chesson HW et al. The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States. Sex Transm Dis. 2014;41:660-4 Chesson HW et al. The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States. Sex Transm Dis. 2014;41:660-4
29.
Zurück zum Zitat D'Souza G et al. Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer. Ann Oncol. 2017;28:3065-9 D'Souza G et al. Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer. Ann Oncol. 2017;28:3065-9
30.
Zurück zum Zitat Kero K et al. Smoking increases oral HPV persistence among men: 7-year follow-up study. Eur J Clin Microbiol Infect Dis. 2014;33:123-33 Kero K et al. Smoking increases oral HPV persistence among men: 7-year follow-up study. Eur J Clin Microbiol Infect Dis. 2014;33:123-33
31.
Zurück zum Zitat Rautava J et al. Prevalence, Genotype Distribution and Persistence of Human Papillomavirus in Oral Mucosa of Women: A Six-Year Follow-Up Study. PLoS One. 2012;7,:e42171 Rautava J et al. Prevalence, Genotype Distribution and Persistence of Human Papillomavirus in Oral Mucosa of Women: A Six-Year Follow-Up Study. PLoS One. 2012;7,:e42171
32.
Zurück zum Zitat Gillison ML et al. Prevalence of Oral HPV Infection in the United States, 2009-2010. JAMA. 2012;307:693-703 Gillison ML et al. Prevalence of Oral HPV Infection in the United States, 2009-2010. JAMA. 2012;307:693-703
33.
Zurück zum Zitat Chaturvedi AK et al. Incidence Trends for Human Papillomavirus-Related and -Unrelated Oral Squamous Cell Carcinomas in the United States. J Clin Oncol. 2008;26:612-9 Chaturvedi AK et al. Incidence Trends for Human Papillomavirus-Related and -Unrelated Oral Squamous Cell Carcinomas in the United States. J Clin Oncol. 2008;26:612-9
34.
Zurück zum Zitat Herrero R et al. Human Papillomavirus and Oral Cancer: The International Agency for Research on Cancer Multicenter Study. J Natl Cancer Inst. 2003;95:1772-83 Herrero R et al. Human Papillomavirus and Oral Cancer: The International Agency for Research on Cancer Multicenter Study. J Natl Cancer Inst. 2003;95:1772-83
35.
Zurück zum Zitat Drake VE et al. Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer. Cancer. 2021;127:1029-38 Drake VE et al. Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer. Cancer. 2021;127:1029-38
36.
Zurück zum Zitat D'Souza G et al. Case-Control Study of Human Papillomavirus and Oropharyngeal Cancer. N Engl J Med. 2007;356:1944-56 D'Souza G et al. Case-Control Study of Human Papillomavirus and Oropharyngeal Cancer. N Engl J Med. 2007;356:1944-56
37.
Zurück zum Zitat Farsi NJ et al. Sexual behaviours and head and neck cancer: A systematic review and meta-analysis. Cancer Epidemiol. 2015;39:1036-46 Farsi NJ et al. Sexual behaviours and head and neck cancer: A systematic review and meta-analysis. Cancer Epidemiol. 2015;39:1036-46
38.
Zurück zum Zitat Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol. 2005;32:16-24 Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol. 2005;32:16-24
39.
Zurück zum Zitat Heck JE et al. Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol. 2010;39:166-81 Heck JE et al. Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol. 2010;39:166-81
40.
Zurück zum Zitat Gillison ML et al. Distinct Risk Factor Profiles for Human Papillomavirus Type 16-Positive and Human Papillomavirus Type 16-Negative Head and Neck Cancers.," J natl Cancer Inst. 2008;100:407-20 Gillison ML et al. Distinct Risk Factor Profiles for Human Papillomavirus Type 16-Positive and Human Papillomavirus Type 16-Negative Head and Neck Cancers.," J natl Cancer Inst. 2008;100:407-20
41.
Zurück zum Zitat Manhart LE, Koutsky LA. Do Condoms Prevent Genital HPV Infection, External Genital Warts, or Cervical Neoplasia? Sex Transm Dis. 2002;29:725-35 Manhart LE, Koutsky LA. Do Condoms Prevent Genital HPV Infection, External Genital Warts, or Cervical Neoplasia? Sex Transm Dis. 2002;29:725-35
42.
Zurück zum Zitat Nielson CM et al. Consistent Condom Use Is Associated with Lower Prevalence of Human Papillomavirus Infection in Men. J Infect Dis. 2010;202:445-51 Nielson CM et al. Consistent Condom Use Is Associated with Lower Prevalence of Human Papillomavirus Infection in Men. J Infect Dis. 2010;202:445-51
43.
Zurück zum Zitat Kjaer SK et al. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev. 2001;10:101-6 Kjaer SK et al. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev. 2001;10:101-6
44.
Zurück zum Zitat Beachler DC et al. Risk Factors for Acquisition and Clearance of Oral Human Papillomavirus Infection Among HIV-Infected and HIV-Uninfected Adults Am J Epidemiol. 2015;181:40-53 Beachler DC et al. Risk Factors for Acquisition and Clearance of Oral Human Papillomavirus Infection Among HIV-Infected and HIV-Uninfected Adults Am J Epidemiol. 2015;181:40-53
45.
Zurück zum Zitat Giuliano AR et al. EUROGIN 2014 roadmap: Differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int J Cancer. 2015;136:2752-60 Giuliano AR et al. EUROGIN 2014 roadmap: Differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int J Cancer. 2015;136:2752-60
46.
Zurück zum Zitat D'Souza G, Dempsey A. The role of HPV in head and neck cancer and review of the HPV vaccine. Prev Med. 2011;53(Suppl 1):S5-S11 D'Souza G, Dempsey A. The role of HPV in head and neck cancer and review of the HPV vaccine. Prev Med. 2011;53(Suppl 1):S5-S11
47.
Zurück zum Zitat Safaeian M et al. Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections. J Natl Cancer Inst. 2010;102:1653-62 Safaeian M et al. Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections. J Natl Cancer Inst. 2010;102:1653-62
48.
Zurück zum Zitat Ho GYF et al. Risk Factors for Subsequent Cervicovaginal Human Papillomavirus (HPV) Infection and the Protective Role of Antibodies to HPV-16 Virus-Like Particles. J Infect Dis. 2002;186:737-42 Ho GYF et al. Risk Factors for Subsequent Cervicovaginal Human Papillomavirus (HPV) Infection and the Protective Role of Antibodies to HPV-16 Virus-Like Particles. J Infect Dis. 2002;186:737-42
49.
Zurück zum Zitat Herrero R et al. Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica. PLoS One. 2013;8:e68329 Herrero R et al. Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica. PLoS One. 2013;8:e68329
50.
Zurück zum Zitat Kreimer AR et al. Evaluation of Human Papillomavirus Antibodies and Risk of Subsequent Head and Neck Cancer. J Clin Oncol. 2013;31:2708-15 Kreimer AR et al. Evaluation of Human Papillomavirus Antibodies and Risk of Subsequent Head and Neck Cancer. J Clin Oncol. 2013;31:2708-15
51.
Zurück zum Zitat Lu B et al. Prevalent Serum Antibody Is Not a Marker of Immune Protection against Acquisition of Oncogenic HPV16 in Men. Cancer Res. 2021;72:676-85 Lu B et al. Prevalent Serum Antibody Is Not a Marker of Immune Protection against Acquisition of Oncogenic HPV16 in Men. Cancer Res. 2021;72:676-85
52.
Zurück zum Zitat D'Souza G et al. Oral Human Papillomavirus (HPV) Infection in HPV-Positive Patients With Oropharyngeal Cancer and Their Partners. J Clin Oncol. 2014;32:2408-15 D'Souza G et al. Oral Human Papillomavirus (HPV) Infection in HPV-Positive Patients With Oropharyngeal Cancer and Their Partners. J Clin Oncol. 2014;32:2408-15
53.
Zurück zum Zitat Vogt SL et al. Concordant Oral-Genital HPV Infection in South Africa Couples: Evidence for Transmission. Front. Oncol. 2013;3:303 Vogt SL et al. Concordant Oral-Genital HPV Infection in South Africa Couples: Evidence for Transmission. Front. Oncol. 2013;3:303
54.
Zurück zum Zitat Rintala M et al. Natural history of oral papillomavirus infections in spouses: A prospective Finnish HPV Family Study. J Clin Virol. 2006;35:89-94 Rintala M et al. Natural history of oral papillomavirus infections in spouses: A prospective Finnish HPV Family Study. J Clin Virol. 2006;35:89-94
55.
Zurück zum Zitat Mirghani H et al. Is there an increased risk of cancer among spouses of patients with an HPV-related cancer: A systematic review. Oral Oncol. 2017;67:138-45 Mirghani H et al. Is there an increased risk of cancer among spouses of patients with an HPV-related cancer: A systematic review. Oral Oncol. 2017;67:138-45
56.
Zurück zum Zitat Szymonowicz KA, Chen J. Biological and clinical aspects of HPV-related cancers. Cancer Biol Med. 2020;17:864-78 Szymonowicz KA, Chen J. Biological and clinical aspects of HPV-related cancers. Cancer Biol Med. 2020;17:864-78
57.
Zurück zum Zitat Gillison ML et al. Human Papillomavirus and Diseases of the Upper Airway: Head and Neck Cancer and Respiratory Papillomatosis. Vaccine. 2021;30(Supp 5):F34-54 Gillison ML et al. Human Papillomavirus and Diseases of the Upper Airway: Head and Neck Cancer and Respiratory Papillomatosis. Vaccine. 2021;30(Supp 5):F34-54
58.
Zurück zum Zitat Chi AC et al. Oral cavity and oropharyngeal squamous cell carcinoma-an update. CA Cancer J Clin. 2015;65:401-21 Chi AC et al. Oral cavity and oropharyngeal squamous cell carcinoma-an update. CA Cancer J Clin. 2015;65:401-21
59.
Zurück zum Zitat Elrefaey S et al. HPV in oropharyngeal cancer: the basics to know in clinical practice. Acta Otorhinolaryngol Ital. 2014;34:299-309 Elrefaey S et al. HPV in oropharyngeal cancer: the basics to know in clinical practice. Acta Otorhinolaryngol Ital. 2014;34:299-309
60.
Zurück zum Zitat Evans M et al. Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population. BMC Cancer. 2013;13:220 Evans M et al. Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population. BMC Cancer. 2013;13:220
61.
Zurück zum Zitat Berman TA, Schiller JT. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases. Cancer. 2017;123:2219-29 Berman TA, Schiller JT. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases. Cancer. 2017;123:2219-29
Metadaten
Titel
Steigende Inzidenz
HPV-assoziierte Oropharynxkarzinome: Einschätzung des Erkrankungsrisikos
verfasst von
Dr. med. Christian Jacobi
Dr. med. Ivelina Stoycheva
Publikationsdatum
19.04.2022
Verlag
Springer Medizin
Erschienen in
HNO Nachrichten / Ausgabe 2/2022
Print ISSN: 0177-1000
Elektronische ISSN: 2198-6533
DOI
https://doi.org/10.1007/s00060-022-7734-8